Adjuvants, Immunologic/therapeutic use
Adolescent
Adult
Aged
Combined Modality Therapy
Disease-Free Survival
Female
Humans
*Immunotherapy, Adoptive
Interleukin-2/therapeutic use
Lymphatic Metastasis
Lymphocytes, Tumor-Infiltrating/*transplantation
Male
Melanoma/diagnosis/mortality/*therapy
Middle Aged
Survival Rate
T-Lymphocytes/immunology
